Rahat Husain, MD (Res), FRCOphth; Tan Do, MD, PhD; Jimmy Lai, FRCEd; et al.
free access
JAMA Ophthalmol. 2019;137(10):1107-1113. doi:10.1001/jamaophthalmol.2019.2493
This randomized clinical trial compares the intraocular pressure outcome after 1 year in patients with synechial primary angle-closure disease and cataract who underwent phacoemulsification combined with goniosynechialysis compared with phacoemulsification without goniosynechialysis.
Scott Johnson, PhD, MHA; Marric Buessing, PhD; Thomas O’Connell, MA; et al.
open access
JAMA Ophthalmol. 2019;137(10):1115-1123. doi:10.1001/jamaophthalmol.2019.2512
This economic analysis evaluates the incremental cost-effectiveness ratio for use of voretigene neparvovec-rzyl vs standard care in patients with RPE65-mediated inherited retinal disease.
-
Invited Commentary
Cost-effectiveness of Voretigene Neparvovec-rzyl Therapy
Nicolas A. Yannuzzi, MD; William E. Smiddy, MD
Hyung Bin Lim, MD; Yong Il Shin, MD; Min Woo Lee, MD; et al.
free access
JAMA Ophthalmol. 2019;137(10):1125-1132. doi:10.1001/jamaophthalmol.2019.2537
This study investigates longitudinal changes in the peripapillary retinal nerve fiber layer in patients with type 2 diabetes and with or without diabetic retinopathy.
-
Invited Commentary
Diabetic Retinal Neurodegeneration—Should We Redefine Retinopathy From Diabetes?
Elliott H. Sohn, MD; Ian C. Han, MD; Michael D. Abramoff, MD, PhD
Rupert W. Strauss, MD; Xiangrong Kong, PhD; Alexander Ho, BSE; et al.
free access
has audio
JAMA Ophthalmol. 2019;137(10):1134-1145. doi:10.1001/jamaophthalmol.2019.2885
This cohort study estimates the progression rate of atrophic lesions over a 12-month period in the eyes of individuals with Stargardt disease.
-
Audio Author Interview:
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period
Alex D. Hwang, PhD; Merve Tuccar-Burak, MS; Eli Peli, MSc, OD
free access
has active quiz
JAMA Ophthalmol. 2019;137(10):1147-1153. doi:10.1001/jamaophthalmol.2019.2893
This cohort study examines the use of yellow-lens glasses for detection of pedestrians during night driving by younger and older individuals.
Jenna Tauber, MD, MSCI; Ijeoma Chinwuba, MD; David Kleyn; et al.
free access
JAMA Ophthalmol. 2019;137(10):1156-1163. doi:10.1001/jamaophthalmol.2019.2901
This qualitative evaluation investigates the financial and environmental costs of unused pharmaceutical products after phacoemulsification surgery among US surgical sites.
Martin Gliem, MD; Johannes Birtel, MD; Philipp L. Müller, MD; et al.
free access
JAMA Ophthalmol. 2019;137(10):1165-1173. doi:10.1001/jamaophthalmol.2019.2910
This case series describes the characteristics of acute retinopathy and fundus changes among patients with pseudoxanthoma elasticum.
Anna M. Gruener, BMBS, MSc, FRCOphth; Ali Poostchi, MBChB, FRCOphth; Andrew R. Carey, MD; et al.
free access
has active quiz
JAMA Ophthalmol. 2019;137(10):1175-1179. doi:10.1001/jamaophthalmol.2019.2919
This cohort study examines the incidence of biopsy-proven giant cell arteritis in a tertiary care center–based population with a sizeable proportion of black patients.
Sundaram Natarajan, MD; Astha Jain, MD; Radhika Krishnan, MD; et al.
open access
JAMA Ophthalmol. 2019;137(10):1182-1188. doi:10.1001/jamaophthalmol.2019.2923
This cross-sectional study compares the diagnostic accuracy of a smartphone-based artificial intelligence system vs ophthalmologist judgement in patients with referable diabetic retinopathy or any diabetic retinopathy in Mumbai, India.